These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7849493)

  • 1. Intracellular susceptibility to ribozymes in a tethered substrate-ribozyme provirus model is not predicted by secondary structures of human immunodeficiency virus type 1 RNAs in vitro.
    Dropulić B; Jeang KT
    Antisense Res Dev; 1994; 4(3):217-21. PubMed ID: 7849493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis.
    Paik SY; Banerjea A; Chen CJ; Ye Z; Harmison GG; Schubert M
    Hum Gene Ther; 1997 Jun; 8(9):1115-24. PubMed ID: 9189769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites.
    Hotchkiss G; Maijgren-Steffensson C; Ahrlund-Richter L
    Mol Ther; 2004 Jul; 10(1):172-80. PubMed ID: 15233952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
    Chen CJ; Banerjea AC; Harmison GG; Haglund K; Schubert M
    Nucleic Acids Res; 1992 Sep; 20(17):4581-9. PubMed ID: 1408760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme.
    Ojwang JO; Hampel A; Looney DJ; Wong-Staal F; Rappaport J
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10802-6. PubMed ID: 1438280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of structure in a long target RNA on ribozyme cleavage efficiency.
    Campbell TB; McDonald CK; Hagen M
    Nucleic Acids Res; 1997 Dec; 25(24):4985-93. PubMed ID: 9396806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of five highly conserved target sites within the HIV-1 RNA for their susceptibility to hammerhead ribozyme-mediated cleavage in vitro and in vivo.
    Ramezani A; Joshi S
    Antisense Nucleic Acid Drug Dev; 1996; 6(3):229-35. PubMed ID: 8915508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
    Bramlage B; Luzi E; Eckstein F
    Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes.
    Zhou C; Bahner IC; Larson GP; Zaia JA; Rossi JJ; Kohn EB
    Gene; 1994 Nov; 149(1):33-9. PubMed ID: 7958986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
    Sun LQ; Wang L; Gerlach WL; Symonds G
    Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcripts containing a small anti-HIV hammerhead ribozyme that are active in the cell cytoplasm but inactive in vitro as free RNAs.
    Domi A; Beaud G; Favre A
    Biochimie; 1996; 78(7):654-62. PubMed ID: 8955908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition.
    Zhou C; Bahner I; Rossi JJ; Kohn DB
    Antisense Nucleic Acid Drug Dev; 1996; 6(1):17-24. PubMed ID: 8783792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of a U5 ribozyme: intracellular suppression of human immunodeficiency virus type 1 expression.
    Dropulić B; Lin NH; Martin MA; Jeang KT
    J Virol; 1992 Mar; 66(3):1432-41. PubMed ID: 1738200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol.
    Giordano V; Jin DY; Rekosh D; Jeang KT
    Virology; 2000 Feb; 267(2):174-84. PubMed ID: 10662613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribozyme-mediated cleavage of an HIV-1 gag RNA: the effects of nontargeted sequences and secondary structure on ribozyme cleavage activity.
    Taylor NR; Rossi JJ
    Antisense Res Dev; 1991; 1(2):173-86. PubMed ID: 1726777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel ribozyme target site located in the HIV-1 nef open reading frame.
    Larsson S; Hotchkiss G; Su J; Kebede T; Andäng M; Nyholm T; Johansson B; Sönnerborg A; Vahlne A; Britton S; Ahrlund-Richter L
    Virology; 1996 May; 219(1):161-9. PubMed ID: 8623525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A helix 1-extended hairpin ribozyme exhibits altered cleavage behavior in vitro.
    Moosbauer J; Tabler M
    Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):79-87. PubMed ID: 9149843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of highly structured viral RNA molecules by combinatorial libraries of hairpin ribozymes. The most effective ribozymes are not predicted by substrate selection rules.
    Yu Q; Pecchia DB; Kingsley SL; Heckman JE; Burke JM
    J Biol Chem; 1998 Sep; 273(36):23524-33. PubMed ID: 9722591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribozymes that cleave an RNA sequence from human immunodeficiency virus: the effect of flanking sequence on rate.
    Goodchild J; Kohli V
    Arch Biochem Biophys; 1991 Feb; 284(2):386-91. PubMed ID: 1989522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.